This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...